The FDA has launched a safety study of the abortion pill, also called mifepristone, a step that could pave the way for the Trump administration to restrict how it is distributed and used, the Wall Street Journal reported on Thursday. The FDA has said mifepristone continues to be safe and effective for its intended purpose when used as directed. Reuters could not immediately verify the report. The FDA did not immediately respond to a Reuters request for comment outside regular office hours. In May, the U.S. Supreme Court ensured the abortion pill could continue to be prescribed through telemedicine and dispensed by mail when it restored a 2023 federal rule that had made access to the medication easier while a challenge brought by Republican-governed Louisiana made its way through the courts. The study, which has the White House’s backing, would use existing drug-safety systems, is expected to take six months and is intended to withstand legal criticism, the report said. The FDA is also
FDA launches study of abortion
Categories:
Australian fertility rate falls to new record-lowAustralian fertility rate falls to new record-low
Australia’s fertility rate fell to a new record-low for the second straight year in 2024.According to the data from the Australian Bureau of Statistics (ABS), the total fertility rate in
1 dead, 3 injured in multi-vehicle crash in central Japan1 dead, 3 injured in multi-vehicle crash in central Japan
One person has died and three others were injured in a multi-vehicle accident involving more than a dozen vehicles on a national highway in Tochigi Prefecture, north of Tokyo, early
Rubio says Venezuela will ultimately under transitionRubio says Venezuela will ultimately under transition
U.S. Secretary of State Marco Rubio on Tuesday said there will have to be a transition phase in Venezuela and the country will need free and fair elections, though he
